Edokpolo Leonard U, Stavris Karen B, Foster Harris E
Department of Urology, Yale University School of Medicine , New Haven , Connecticut.
Top Spinal Cord Inj Rehabil. 2012 Spring;18(2):187-92. doi: 10.1310/sci1802-187.
To study the association of recurrent symptomatic urinary tract infections (UTIs) with the long-term use of clean intermittent catheterization (CIC) for the management of neurogenic bladder in patients with spinal cord injury (SCI).
Retrospective study of 61 SCI patients with neurogenic bladder managed by CIC. Subjects were selected from 210 SCI patients seen at the Yale Urology Medical Group between 2000 and 2010. Medical UTI prophylaxis (PRx) with oral antimicrobials or methenamine/ascorbic acid was used to identify patients with recurrent UTI. The number of positive cultures (≥10(3) cfu/mL) within a year prior to starting PRx was used to confirm the recurrence of UTI.
Fifty-one male and 10 female subjects were managed with CIC. Forty-one (67%) subjects were placed on medical PRx for symptomatic recurrent UTI. Seventeen (28%) subjects had at least 3 positive cultures within the year prior to starting PRx. Fifteen of 20 (75%) subjects not on PRx had no complaints of UTI symptoms in the final year of follow-up.
Recurrent symptomatic UTIs remain a major complication of long-term CIC in SCI patients. Although CIC is believed to have the fewest number of complications, many SCI patients managed with long-term CIC are started on medical PRx early in the course of management. Future studies are needed to determine the efficacy of routine UTI PRx in these patients as well as determine what factors influence why many patients on CIC experience frequent infections and others do not.
研究复发性症状性尿路感染(UTI)与脊髓损伤(SCI)患者长期使用清洁间歇性导尿(CIC)治疗神经源性膀胱之间的关联。
对61例采用CIC治疗神经源性膀胱的SCI患者进行回顾性研究。研究对象选自2000年至2010年间在耶鲁大学泌尿外科医疗集团就诊的210例SCI患者。采用口服抗菌药物或乌洛托品/抗坏血酸进行医学性UTI预防(PRx)以确定复发性UTI患者。启动PRx前一年内阳性培养物数量(≥10³ cfu/mL)用于确认UTI复发。
51例男性和10例女性接受了CIC治疗。41例(67%)患者因症状性复发性UTI接受医学性PRx治疗。17例(28%)患者在启动PRx前一年内至少有3次阳性培养物。20例未接受PRx治疗的患者中有15例(75%)在随访的最后一年无UTI症状主诉。
复发性症状性UTI仍然是SCI患者长期CIC治疗的主要并发症。尽管CIC被认为并发症最少,但许多接受长期CIC治疗的SCI患者在治疗过程早期就开始接受医学性PRx治疗。未来需要开展研究以确定常规UTI PRx对这些患者的疗效,以及确定哪些因素影响为何许多接受CIC治疗的患者频繁感染而其他患者则不然。